drugset / Trial / NCT00829452
Ramipril 10 mg Capsule in Healthy Subjects Under Fasting Conditions
RandomizedCrossoverOpen-labelOther
Summary
The objective of this study is to compare the rate and extent of absorption of Ramipril 10 mg capsule (test) versus Altace® (reference) administered as the content of 1 x 10 mg capsule mixed with applesauce under fasting conditions.
Timeline
- Start
- 2004-08
- Primary completion
- 2004-10
- Completion
- 2004-10
Outcome
Met primary endpoint
registry Ratio of the T/R geometric mean x 100 96.03 (90% CI 89.11 to 103.49) NCT00829452 ↗
registry Ratio of the T/R geometric mean x 100 95.34 (90% CI 90.82 to 100.09) NCT00829452 ↗
registry Ratio of the T/R geometric mean x 100 96.98 (90% CI 92.73 to 101.42) NCT00829452 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ramipril | Small molecule | 10 mg | — |
Indications
No indication recorded.